Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.010
-0.020 (-0.99%)
At close: Mar 30, 2026, 4:00 PM EDT
2.020
+0.010 (0.50%)
Pre-market: Mar 31, 2026, 7:00 AM EDT
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $56.99 million as of March 31, 2026. Its market cap has increased by 71.04% in one year.
Market Cap
56.99M
Enterprise Value
37.46M
1-Year Change
71.04%
Ranking
Category
Stock Price
$2.01
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $56.99M, a decrease of -8.82%. That is a compound annual growth rate of -1.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 56.99M | -37.85% |
| Dec 31, 2025 | 91.70M | 32.13% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Impact BioMedical | 61.98M |
| iBio, Inc. | 60.80M |
| eXoZymes | 60.06M |
| Alterity Therapeutics | 59.92M |
| ImmuCell | 58.98M |
| TScan Therapeutics | 56.25M |
| ImageneBio | 55.92M |
| OnKure Therapeutics | 54.56M |